These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17045188)

  • 1. Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials.
    Khush KK; Waters DD
    J Card Fail; 2006 Oct; 12(8):664-74. PubMed ID: 17045188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin use in heart failure: a cause for concern?
    Raina A; Pickering T; Shimbo D
    Am Heart J; 2006 Jul; 152(1):39-49. PubMed ID: 16824830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins in heart failure. Beyond the lipid lowering effect.
    Tousoulis D; Charakida M; Stefanadi E; Siasos G; Latsios G; Stefanadis C
    Int J Cardiol; 2007 Feb; 115(2):144-50. PubMed ID: 17175040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug insight: statins for nonischemic heart failure--evidence and potential mechanisms.
    Lipinski MJ; Abbate A; Fuster V; Vetrovec GW
    Nat Clin Pract Cardiovasc Med; 2007 Apr; 4(4):196-205. PubMed ID: 17380165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of statins in heart failure.
    Gullestad L; Oie E; Ueland T; Yndestad A; Aukrust P
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():35-40. PubMed ID: 18001320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical investigations of statins in heart failure: ventricular function and anti-remodeling.
    Krum H
    Heart Fail Clin; 2008 Apr; 4(2):177-86. PubMed ID: 18433698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin therapy in heart failure: prognostic effects and potential mechanisms.
    Shanes JG; Minadeo KN; Moret A; Groner M; Tabaie SA
    Am Heart J; 2007 Oct; 154(4):617-23. PubMed ID: 17892981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical outcome trials of statins in heart failure.
    Fonarow GC
    Heart Fail Clin; 2008 Apr; 4(2):225-9. PubMed ID: 18433703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy.
    Ramasubbu K; Estep J; White DL; Deswal A; Mann DL
    J Am Coll Cardiol; 2008 Jan; 51(4):415-26. PubMed ID: 18222351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of statins on endothelium, inflammation and cardioprotection.
    Elrod JW; Lefer DJ
    Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG
    Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and clinical outcomes in heart failure.
    Martin JH; Krum H
    Clin Sci (Lond); 2007 Aug; 113(3):119-27. PubMed ID: 17600528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy.
    Li JJ; Li YS; Chen J; Yang JQ
    Med Hypotheses; 2006; 66(6):1199-204. PubMed ID: 16413682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects.
    Miida T; Takahashi A; Ikeuchi T
    Pharmacol Ther; 2007 Feb; 113(2):378-93. PubMed ID: 17113151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early vascular benefits of statin therapy.
    Tsiara S; Elisaf M; Mikhailidis DP
    Curr Med Res Opin; 2003; 19(6):540-56. PubMed ID: 14594527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin withdrawal: clinical implications and molecular mechanisms.
    Cubeddu LX; Seamon MJ
    Pharmacotherapy; 2006 Sep; 26(9):1288-96. PubMed ID: 16945051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of statins in heart failure: beyond its cholesterol-lowering effect.
    Kurian KC; Rai P; Sankaran S; Jacob B; Chiong J; Miller AB
    J Card Fail; 2006 Aug; 12(6):473-8. PubMed ID: 16911915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
    Krum H; Ashton E; Reid C; Kalff V; Rogers J; Amarena J; Singh B; Tonkin A
    J Card Fail; 2007 Feb; 13(1):1-7. PubMed ID: 17338996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-atherosclerotic effects of statins: lessons from prevention trials.
    Ganesh SK; Nass CM; Blumenthal RS
    J Cardiovasc Risk; 2003 Jun; 10(3):155-9. PubMed ID: 12775947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observational studies of statins in systolic heart failure.
    Levy WC
    Heart Fail Clin; 2008 Apr; 4(2):201-8. PubMed ID: 18433700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.